article · Journal of Essential Oil Bearing Plants
Healthcare-associated infections and the increasing prevalence of antibiotic-resistant pathogens represent a significant public health concern. This study aimed, for the first time, to investigate the chemical composition, antioxidant capacity, and antimicrobial activity of the essential oils (EOs) of <i>Thymus glandulosus</i> and <i>Mentha suaveolens</i> Ehrh subsp. <i>eu-rotundifolia</i> against selected nosocomial pathogens. Additionally, an <i>in silico</i> molecular docking and ADMET prediction were performed to support the experimental findings. GC-MS analysis showed that <i>T. glandulosus</i> EO was rich in carvacrol (50.67%), <i>o</i>-cymene (26.34%), and thymol (12.15%), whereas the EO of <i>M. suaveolens</i> Ehrh subsp. <i>eu-rotundifolia</i> was predominantly composed of nepetalactone (85.38%) and D-limonene (4.72%). Antimicrobial assays demonstrated that <i>T. glandulosus</i> EO exhibited strong activity, particularly against Methicillin-resistant <i>Staphylococcus aureus, S. aureus</i>, <i>Escherichia coli, Pseudomonas aeruginosa,</i> and <i>Candida albicans</i>, with inhibition zone diameters (IZ) and MIC values ranging from 23.00 to 52.66 mm and from 2.35 to 9.40 mg/mL, respectively. In contrast, <i>M. suaveolens</i> Ehrh subsp. <i>eu-rotundifolia</i> EO revealed moderate antibacterial activity (IZ = 12.33-50 mm; MIC = 3.86-30.90 mg/mL) and good antifungal activity against yeast strains (IZ = 25.66-33.33 mm; MIC = 3.86-7.72 mg/mL). Regarding the antioxidant assays, <i>T. glandulosus</i> EO displayed higher potency, with IC values of 0.086 ± 0.001 mg/mL (DPPH) and 0.066 ± 0.001mg/mL (FRP). Molecular docking and ADMET analysis were consistent with the <i>in vitro</i> findings, supporting the traditional use of these plants as natural agents for managing nosocomial infections and oxidative stress.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1080/0972060x.2025.2602899
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.